AC Immune SA (ACIU)
2.11
-0.15
(-6.64%)
USD |
NASDAQ |
Jun 10, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
AC Immune SG&A Expense (Quarterly) : 5.326M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 5.326M |
| December 31, 2025 | 5.248M |
| September 30, 2025 | 4.458M |
| June 30, 2025 | 4.717M |
| March 31, 2025 | 4.942M |
| December 31, 2024 | 4.541M |
| September 30, 2024 | 4.332M |
| June 30, 2024 | 5.032M |
| March 31, 2024 | 5.685M |
| December 31, 2023 | 4.568M |
| September 30, 2023 | 3.922M |
| June 30, 2023 | 4.095M |
| March 31, 2023 | 4.438M |
| December 31, 2022 | 4.109M |
| September 30, 2022 | 3.386M |
| June 30, 2022 | 4.532M |
| March 31, 2022 | 4.509M |
| December 31, 2021 | 3.164M |
| September 30, 2021 | 5.903M |
| June 30, 2021 | 5.75M |
| March 31, 2021 | 4.788M |
| December 31, 2020 | 5.536M |
| September 30, 2020 | 5.318M |
| June 30, 2020 | 4.313M |
| March 31, 2020 | 4.651M |
| Date | Value |
|---|---|
| December 31, 2019 | 5.276M |
| September 30, 2019 | 4.012M |
| June 30, 2019 | 3.575M |
| March 31, 2019 | 3.304M |
| December 31, 2018 | 3.777M |
| September 30, 2018 | 2.978M |
| June 30, 2018 | 3.110M |
| March 31, 2018 | 2.859M |
| December 31, 2017 | 3.118M |
| September 30, 2017 | 2.616M |
| June 30, 2017 | 2.203M |
| March 31, 2017 | 2.378M |
| December 31, 2016 | 3.427M |
| September 30, 2016 | 1.756M |
| June 30, 2016 | 1.907M |
| March 31, 2016 | 0.9046M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.9222M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 556.75M |
| CRISPR Therapeutics AG | 17.18M |
| Idorsia Ltd. | 77.58M |
| ADC Therapeutics SA | 22.60M |
| MoonLake Immunotherapeutics | 15.51M |